Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...
Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...
A HEALTHY 78-year-old man went to his dentist with a wobbly lower left pre-molar, hoping for a quick fix. After evaluating the situation, the dentist decided the best course of action was to ...
Importantly, higher CTC counts correlated with measures of prostate cancer severity, including PSA levels, numbers of metastases in bone, and other indicators. "This research emphasizes the ...